Compare CELC & BBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CELC | BBT |
|---|---|---|
| Founded | 2011 | 1846 |
| Country | United States | United States |
| Employees | N/A | 2050 |
| Industry | Medical Specialities | Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.1B | 2.7B |
| IPO Year | 2017 | N/A |
| Metric | CELC | BBT |
|---|---|---|
| Price | $120.90 | $31.88 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 9 | 4 |
| Target Price | ★ $112.56 | $33.25 |
| AVG Volume (30 Days) | ★ 649.3K | 590.3K |
| Earning Date | 05-13-2026 | 04-29-2026 |
| Dividend Yield | N/A | ★ 4.06% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $77.88 |
| Revenue Next Year | $720.19 | $4.31 |
| P/E Ratio | ★ N/A | $29.98 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $9.64 | $22.81 |
| 52 Week High | $129.09 | $32.83 |
| Indicator | CELC | BBT |
|---|---|---|
| Relative Strength Index (RSI) | 52.76 | 58.07 |
| Support Level | $99.38 | $29.17 |
| Resistance Level | N/A | $32.09 |
| Average True Range (ATR) | 7.46 | 0.66 |
| MACD | -0.18 | -0.05 |
| Stochastic Oscillator | 63.82 | 46.45 |
Celcuity Inc is a clinical-stage biotechnology company pursuing development for oncology. The Company's lead therapeutic candidate is gedatolisib, a potent pan-PI3K and mTOR inhibitor. Its mechanism of action and pharmacokinetic properties are differentiated from other currently approved and investigational therapies that target PI3K or mTOR alone or together. A Phase 3 clinical trial, VIKTORIA-1, evaluating gedatolisib in combination with fulvestrant with or without palbociclib in patients with HR+/HER2- advanced breast cancer is currently enrolling patients.
Beacon Financial Corp operates as a multi-bank holding company. It offers commercial, business, and retail banking services, including a full complement of cash management products, online banking services, and consumer and residential loans.